188 related articles for article (PubMed ID: 32739252)
21. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
[TBL] [Abstract][Full Text] [Related]
22. Neuroenergetic Changes in Patients with X-Linked Dystonia-Parkinsonism and Female Carriers.
Prasuhn J; Henkel J; Algodon SM; Uter J; Rosales RL; Klein C; Steinhardt J; Diesta CC; Brüggemann N
Mov Disord Clin Pract; 2024 May; 11(5):550-555. PubMed ID: 38404049
[TBL] [Abstract][Full Text] [Related]
23. Cl-Amidine Prevents Histone 3 Citrullination and Neutrophil Extracellular Trap Formation, and Improves Survival in a Murine Sepsis Model.
Biron BM; Chung CS; O'Brien XM; Chen Y; Reichner JS; Ayala A
J Innate Immun; 2017; 9(1):22-32. PubMed ID: 27622642
[TBL] [Abstract][Full Text] [Related]
24. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
[TBL] [Abstract][Full Text] [Related]
25. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
26. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
Enache D; Pariante CM; Mondelli V
Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
[TBL] [Abstract][Full Text] [Related]
27. Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism.
Goto S; Kawarai T; Morigaki R; Okita S; Koizumi H; Nagahiro S; Munoz EL; Lee LV; Kaji R
Brain; 2013 May; 136(Pt 5):1555-67. PubMed ID: 23599389
[TBL] [Abstract][Full Text] [Related]
28. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
29. Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP).
Mertin R; Diesta C; Brüggemann N; Rosales RL; Hanssen H; Westenberger A; Steinhardt J; Heldmann M; Manalo HTS; Oropilla JQ; Klein C; Helmchen C; Sprenger A
J Neurol; 2023 Sep; 270(9):4262-4275. PubMed ID: 37191726
[TBL] [Abstract][Full Text] [Related]
30. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
Curran AM; Naik P; Giles JT; Darrah E
Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
[TBL] [Abstract][Full Text] [Related]
31. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
32. Striatal dysfunction in X-linked dystonia-parkinsonism is associated with disease progression.
Brüggemann N; Rosales RL; Waugh JL; Blood AJ; Domingo A; Heldmann M; Jamora RD; Münchau A; Münte TF; Lee LV; Buchmann I; Klein C
Eur J Neurol; 2017 May; 24(5):680-686. PubMed ID: 28236370
[TBL] [Abstract][Full Text] [Related]
33. Neuroanatomical changes extend beyond striatal atrophy in X-linked dystonia parkinsonism.
Brüggemann N; Heldmann M; Klein C; Domingo A; Rasche D; Tronnier V; Rosales RL; Jamora RD; Lee LV; Münte TF
Parkinsonism Relat Disord; 2016 Oct; 31():91-97. PubMed ID: 27481033
[TBL] [Abstract][Full Text] [Related]
34. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
35. Understanding XDP through imaging, pathology, and genetics.
Pasco PM; Ison CV; Muňoz EL; Magpusao NS; Cheng AE; Tan KT; Lo RW; Teleg RA; Dantes MB; Borres R; Maranon E; Demaisip C; Reyes MV; Lee LV
Int J Neurosci; 2011; 121 Suppl 1():12-7. PubMed ID: 21034368
[TBL] [Abstract][Full Text] [Related]
36. Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation.
Zheng Q; Osunsade A; David Y
Nat Commun; 2020 Jun; 11(1):3241. PubMed ID: 32591537
[TBL] [Abstract][Full Text] [Related]
37. Oral diadochokinetic markers of X-linked dystonia-parkinsonism.
Kao TH; Rowe HP; Green JR; Stipancic KL; Sharma N; de Guzman JK; Supnet-Wells ML; Acuna P; Perry BJ
Parkinsonism Relat Disord; 2024 Mar; 120():105991. PubMed ID: 38184995
[TBL] [Abstract][Full Text] [Related]
38. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism.
Goto S; Lee LV; Munoz EL; Tooyama I; Tamiya G; Makino S; Ando S; Dantes MB; Yamada K; Matsumoto S; Shimazu H; Kuratsu J; Hirano A; Kaji R
Ann Neurol; 2005 Jul; 58(1):7-17. PubMed ID: 15912496
[TBL] [Abstract][Full Text] [Related]
39. Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.
Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Aguil A; Ganza-Bautista NG; Lagarde JBB; Soria J; Jamora RDG; Acuña PJ; Vanderburg C; Sapp E; DiFiglia M; Murcar MG; Campion L; Ozelius LJ; Alessi AK; Singh-Bains MK; Waldvogel HJ; Faull RLM; Macalintal-Canlas R; Muñoz EL; Penney EB; Ang MA; Diesta CCE; Bragg DC; Acuña-Sunshine G
J Neural Transm (Vienna); 2021 Apr; 128(4):575-587. PubMed ID: 33439365
[TBL] [Abstract][Full Text] [Related]
40. Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
Rakovic A; Domingo A; Grütz K; Kulikovskaja L; Capetian P; Cowley SA; Lenz I; Brüggemann N; Rosales R; Jamora D; Rolfs A; Seibler P; Westenberger A; König I; Klein C
Mov Disord; 2018 Jul; 33(7):1108-1118. PubMed ID: 30153385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
